Early remdesivir treatment in COVID-19: Why wait another day?
作者信息
Cubeddu Luigi X, Cubeddu Robert J
机构信息
Department of Pharmaceutical Sciences, Health Professions Division, COP, Nova SE University, Davie, Florida, USA.
Division of Cardiology, Heart and Vascular Institute, Cleveland Clinic Florida, Weston, Florida, USA.
出版信息
J Med Virol. 2021 Jul;93(7):4078-4080. doi: 10.1002/jmv.26792. Epub 2021 Feb 1.
Abstract
摘要
相似文献
1
Early remdesivir treatment in COVID-19: Why wait another day?新冠疫情中早期使用瑞德西韦治疗：为何还要再等一天？
J Med Virol. 2021 Jul;93(7):4078-4080. doi: 10.1002/jmv.26792. Epub 2021 Feb 1.
2
Remdesivir in The Treatment of COVID-19.瑞德西韦治疗 COVID-19。
Am J Nurs. 2021 Jan 1;121(1):55. doi: 10.1097/01.NAJ.0000731668.01845.8c.
3
A Potential Antiviral Treatment for COVID-19: Remdesivir.一种针对新冠病毒病的潜在抗病毒疗法：瑞德西韦。
Clin Nurse Spec. 2020 Nov/Dec;34(6):257-260. doi: 10.1097/NUR.0000000000000549.
4
COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.2019冠状病毒病最新情况：瑞德西韦（Veklury）用于高危2019冠状病毒病门诊患者。
Med Lett Drugs Ther. 2022 Feb 21;64(1644):31-32.
5
Remdesivir: a pendulum in a pandemic.瑞德西韦：大流行中的钟摆。
BMJ. 2020 Nov 24;371:m4560. doi: 10.1136/bmj.m4560.
6
Update Alert 2: Remdesivir for Adults With COVID-19.最新警报2：用于成人新冠肺炎患者的瑞德西韦。
Ann Intern Med. 2021 Dec;174(12):W114-W115. doi: 10.7326/L21-0600. Epub 2021 Oct 5.
7
Remdesivir for patients with COVID-19.瑞德西韦用于治疗新冠肺炎患者。
CMAJ. 2021 Jan 25;193(4):E125. doi: 10.1503/cmaj.202505. Epub 2021 Jan 6.
8
Remdesivir for the treatment of COVID-19 in pregnancy.瑞德西韦用于治疗妊娠期新型冠状病毒肺炎
J Med Virol. 2021 Jul;93(7):4114-4119. doi: 10.1002/jmv.26986. Epub 2021 Apr 14.
9
Remdesivir for COVID-19 in Europe: will it provide value for money?瑞德西韦在欧洲治疗新冠病毒肺炎：它是否具有性价比？
Lancet Respir Med. 2021 Feb;9(2):127-128. doi: 10.1016/S2213-2600(20)30568-3. Epub 2020 Dec 17.
10
Assessing the evidence on remdesivir.评估关于瑞德西韦的证据。
Lancet Infect Dis. 2021 Dec;21(12):1630-1631. doi: 10.1016/S1473-3099(21)00695-2.
引用本文的文献
1
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study.住院COVID-19患者对瑞德西韦的快速反应：一项倾向评分加权多中心队列研究。
Infect Dis Ther. 2023 Oct;12(10):2471-2484. doi: 10.1007/s40121-023-00874-2. Epub 2023 Oct 6.
2
Early initiation of remdesivir and its effect on oxygen desaturation: A clinical review study among high-risk COVID-19 patients in Myanmar.瑞德西韦的早期使用及其对氧饱和度下降的影响：缅甸高危COVID-19患者的一项临床综述研究。
J Family Med Prim Care. 2022 Aug;11(8):4644-4649. doi: 10.4103/jfmpc.jfmpc_2350_21. Epub 2022 Aug 30.
3
Remdesivir: Quo vadis?瑞德西韦：路在何方？
Biochem Pharmacol. 2021 Nov;193:114800. doi: 10.1016/j.bcp.2021.114800. Epub 2021 Oct 19.
4
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients.诊断 SARS-CoV-2 循环阈值预测 COVID-19 症状患者的疾病严重程度、生存率和六个月后遗症。
Viruses. 2021 Feb 11;13(2):281. doi: 10.3390/v13020281.
Zotero 插件